Postpartum rubella vaccination and anti-D prophylaxis.

Evaluation of an institution-based protocol for postpartum rubella vaccination.

Antibiotic Prophylaxis and Preventing Postpartum Infection

بحث بر روی کاربرد پروفیلاکسی آنتی بیوتیک ها در مامائی، در اواخر سال ۱۹۴۰ شروع شد و تجویز پروفیلاکسی پنی سیلین به تمام بیماران در لیبر باعث کاهش شیوع تب از ۶/۳ به ۴/۲٪ می شود. ولی هرگز آنتی بیوتیک پروفیلاکسی بطور عمومی مورد قبول واقع نشد. بدلیل اینکه اولا شیوع عمومی عفونت، پائین است و عفونتها بندرت شدید می شوند، بطوریکه بیش از ۹۵ تا ۹۷ بیماران احتیاج به آنتی بیوتیک پیدا نمی کنند. شاید، تجویز غیر...

Following up on unfinished business--prenatal rubella screening and postpartum vaccination.

This is an encouraging yet challenging time for rubella vaccination programs in Canada. On the one hand, the national coverage level for the first dose of the measles–mumps–rubella vaccine, estimated at 95%, is the highest of any childhood vaccine given in this country and is just below national coverage goals. On the other hand, the recent study by Theresa Gyorkos and colleagues, reported in t...

Cost-effectiveness of antenatal anti-D prophylaxis.

This paper estimates the incremental cost-effectiveness of providing antenatal anti-D prophylaxis in varying dose sizes to either primigravidae or all Rh D negative women. It presents a model for calculating the net cost per 1000 'at risk' women based on the costs of anti-D prophylaxis and the future NHS costs avoided. Incremental cost-effectiveness is measured in terms of the net cost per Rh D...

Rubella vaccination strategy.

When rubella vaccineswere introduced in 1969 theywere initially used only in industrialized countries. Twomajor strategies were used to prevent the occurrence of congenital rubella syndrome (CRS). In the United States, the strategy aimed to interrupt rubella virus circulation among young children, thereby reducing the possibility of exposure of a susceptible pregnant woman. This was accomplishe...